Cisplatin to Patients With Pancreatic Cancer and Homologous Recombination Deficiency
Status:
Recruiting
Trial end date:
2026-10-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of cisplatin based regimen to patients
with advanced pancreatic cancer and homologous recombination deficiency.